Morphine Prince 109,730 Posted 59 minutes ago Share Posted 59 minutes ago Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients. According to a news release, the mRNA-based vaccine was tested in a late-stage trial involving people who’d already had surgery to remove a melanoma, the deadliest form of skin cancer. The study involved a personalized cancer vaccine called Intismeran, produced by Merck and Moderna, administered in combination with Merck’s cancer immunotherapy Keytruda. Interim results from the trial show that the vaccine-drug combo appeared to extend the time before cancer returned in high-risk patients, according to the release, though the companies did not say for how long. Merck and Moderna described the results as the first breakthrough of its kind. They said the study would continue to examine overall survival rates following the treatment. Source: https://www.nbcnews.com/health/health-news/merck-moderna-say-melanoma-vaccine-promise-prevent-recurrence-cancer-rcna593316 1 Quote Link to post Share on other sites More sharing options...
dynamite 67,121 Posted 48 minutes ago Share Posted 48 minutes ago Moderna - MRNA Like a poem said by a neydy in red Quote Link to post Share on other sites More sharing options...
Featured Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.